Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Inogen Inc
Report date September 17, 2018 · Filed September 19, 2018
Section 16 reporting ended · disclosed 2018-09-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,595 |
Ending reported balance
After 2018-09-17 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2018-09-17 · Exercise / conversion · Acquired 2,000 · Balance 7,595 Row 2 · 2018-09-17 · Sale · Disposed 386 · Balance 7,209 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F2: Represents the weighted average share price of an aggregate total of 386 shares sold in the price range of $275.22 to $276.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2018-09-17 · Sale · Disposed 200 · Balance 7,009 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F3: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $276.45 to $276.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 4 · 2018-09-17 · Sale · Disposed 100 · Balance 6,909 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. Row 5 · 2018-09-17 · Sale · Disposed 100 · Balance 6,809 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. Row 6 · 2018-09-17 · Sale · Disposed 600 · Balance 6,209 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F4: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $282.92 to $283.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 7 · 2018-09-17 · Sale · Disposed 500 · Balance 5,709 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F5: Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $284.48 to $285.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 8 · 2018-09-17 · Sale · Disposed 114 · Balance 5,595 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018. F6: Represents the weighted average share price of an aggregate total of 114 shares sold in the price range of $285.80 to $285.90 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2022-03-28 | Direct | 5,683 |
Reported balance
After 2018-09-17 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-09-17 · Exercise / conversion · Disposed 2,000 · Balance 5,683 F7: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018.
F2: Represents the weighted average share price of an aggregate total of 386 shares sold in the price range of $275.22 to $276.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $276.45 to $276.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $282.92 to $283.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $284.48 to $285.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: Represents the weighted average share price of an aggregate total of 114 shares sold in the price range of $285.80 to $285.90 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2017 Filed Aug 22, 2017 20:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.75 | $1,875.00 |
DisclosureSEC source: 0001209191-17-049819 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 21:00 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049011 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,464 F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on September 1, 2018, and 1/16th of which shall vest every three months thereafter on the 1st of the month. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 19:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-045816 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,181 Underlying: Common Stock · 2,500 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 19:20 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $94.21 | $235,536.50 |
DisclosureSEC source: 0001209191-17-045816 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $93.75 to $94.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 19:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.75 | $1,875.00 |
DisclosureSEC source: 0001209191-17-045816 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 21:40 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-040901 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,681 Underlying: Common Stock · 2,500 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 21:40 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 900 | $91.97 | $82,774.98 |
DisclosureSEC source: 0001209191-17-040901 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 900 shares sold in the price range of $91.84 to $92.19 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 21:40 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,600 | $91.30 | $146,072.96 |
DisclosureSEC source: 0001209191-17-040901 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,233 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 1,600 shares sold in the price range of $90.84 to $91.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 21:40 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.75 | $1,875.00 |
DisclosureSEC source: 0001209191-17-040901 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:25 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-033584 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,181 Underlying: Common Stock · 2,500 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:25 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 400 | $81.92 | $32,767.00 |
DisclosureSEC source: 0001209191-17-033584 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $81.70 to $82.13 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:25 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,100 | $80.81 | $169,693.44 |
DisclosureSEC source: 0001209191-17-033584 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,733 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,100 shares sold in the price range of $80.46 to $81.44 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:25 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.75 | $1,875.00 |
DisclosureSEC source: 0001209191-17-033584 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 769 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-17-027571 · doc4.xml · derivative · entry 6 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,681 Underlying: Common Stock · 769 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is August 1, 2011. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,731 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-17-027571 · doc4.xml · derivative · entry 5 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,731 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:20 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 121 | $76.09 | $9,207.14 |
DisclosureSEC source: 0001209191-17-027571 · doc4.xml · nonDerivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 121 shares sold in the price range of $76.08 to $76.15 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:20 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,379 | $75.24 | $178,993.58 |
DisclosureSEC source: 0001209191-17-027571 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,379 shares sold in the price range of $74.96 to $75.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 769 | $0.75 | $576.75 |
DisclosureSEC source: 0001209191-17-027571 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,731 | $0.60 | $1,038.60 |
DisclosureSEC source: 0001209191-17-027571 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 23:59 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-17-021219 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,731 Underlying: Common Stock · 2,500 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 23:59 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 300 | $74.49 | $22,347.00 |
DisclosureSEC source: 0001209191-17-021219 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 300 shares sold in the price range of $74.41 to $74.64 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 23:59 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,200 | $73.77 | $162,289.16 |
DisclosureSEC source: 0001209191-17-021219 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,633 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,200 shares sold in the price range of $73.32 to $74.27 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 23:59 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.60 | $1,500.00 |
DisclosureSEC source: 0001209191-17-021219 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 23:39 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-17-012360 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,231 Underlying: Common Stock · 2,500 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 23:39 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $68.04 | $170,099.25 |
DisclosureSEC source: 0001209191-17-012360 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $67.840 to $68.275 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 23:39 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.60 | $1,500.00 |
DisclosureSEC source: 0001209191-17-012360 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-17-004657 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,731 Underlying: Common Stock · 2,500 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:08 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $63.91 | $159,767.00 |
DisclosureSEC source: 0001209191-17-004657 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $63.75 to $64.28 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.60 | $1,500.00 |
DisclosureSEC source: 0001209191-17-004657 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 00:47 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-16-155511 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,231 Underlying: Common Stock · 2,500 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 00:47 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $65.13 | $162,822.00 |
DisclosureSEC source: 0001209191-16-155511 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $64.93 to $65.67 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 00:47 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.60 | $1,500.00 |
DisclosureSEC source: 0001209191-16-155511 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 22:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-16-150619 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,731 Underlying: Common Stock · 2,500 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 22:38 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,500 | $63.80 | $159,500.50 |
DisclosureSEC source: 0001209191-16-150619 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $63.64 to $64.07 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 22:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $0.60 | $1,500.00 |
DisclosureSEC source: 0001209191-16-150619 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2016 Filed Oct 14, 2016 19:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,551 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-16-145909 · doc4.xml · derivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,231 Underlying: Common Stock · 4,551 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| October 12, 2016 Filed Oct 14, 2016 19:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,551 | $59.45 | $270,575.15 |
DisclosureSEC source: 0001209191-16-145909 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · price: Represents the weighted average share price of an aggregate total of 4,551 shares sold in the price range of $59.06 to $59.70 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 12, 2016 Filed Oct 14, 2016 19:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,551 | $0.60 | $2,730.60 |
DisclosureSEC source: 0001209191-16-145909 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 19:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,551 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-16-142235 · doc4.xml · derivative · entry 4 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,782 Underlying: Common Stock · 4,551 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 19:20 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 700 | $60.77 | $42,539.98 |
DisclosureSEC source: 0001209191-16-142235 · doc4.xml · nonDerivative · entry 3 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 700 shares sold in the price range of $60.67 to $60.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 19:20 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,851 | $60.07 | $231,342.66 |
DisclosureSEC source: 0001209191-16-142235 · doc4.xml · nonDerivative · entry 2 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,033 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 3,851 shares sold in the price range of $59.67 to $60.63 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 19:20 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,551 | $0.60 | $2,730.60 |
DisclosureSEC source: 0001209191-16-142235 · doc4.xml · nonDerivative · entry 1 Scribner Matt · CIK 0001596087 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.